
In a recent interview, Amir Iravani, MD, FRACP, discussed the radiotherapeutic agent 177Lu-edotreotide and new dosimetry data from the COMPETE trial that was recently presented at the ASTRO conference.
Catch up on the latest imaging research from the recent SNMMI conference.
Take a look back at some of the most viewed research updates from the annual SNMMI conference. Topics ranged from preliminary findings with the alpha-emitting radioconjugate ATNM-400 for prostate cancer and the combination of CT attenuation correction mapping and AI for coronary artery calcium (CAC) risk stratification to significant upstaging with PSMA PET/CT in patients with osseous oligometastatic PCa. Review the slideshow below to see highlighted research updates from the recent SNMMI conference.





